Ken Griffin's position in Humacyte is currently worth $7.54 Million. That's 0.01% of their equity portfolio (1363rd largest holding). The investor owns 1.16% of the outstanding Humacyte stock. The first Humacyte trade was made in Q4 2021. Since then Ken Griffin bought shares eight more times and sold shares on five occasions. The investor's estimated purchase price is $11.2 Million, resulting in a loss of 32%.